¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"secondary inclusion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® secondary infection ÇÑ±Û ÀÌÂ÷°¨¿°
¼³¸í   
  ¾î¶² º´¿øÃ¼ÀÇ °¨¿°¿¡ ÀÇÇÏ¿© º»ÀÎÀÇ ÀúÇ×·ÂÀÌ ¾àÇØÁ³À» ¶§ ¸öÀÇ ´Ù¸¥ ºÎÀ§·Î ÀüÀÌÇÏ¿© ´Ù½Ã °¨¿°À» ÀÏÀ¸Å°´Â °Í. º´¿øÃ¼°¡ ÀÎü¿¡ Ä§ÀÔÇÏ¿© Æ¯Á¤ÇÑ ±â°üÀ̳ª Á¶Á÷¿¡¼­ º´¿øÃ¼°¡ Áõ½ÄÇϰí, ±×°÷¿¡ Æ¯À¯ÀÇ º´Å͸¦ ÀÏÀ¸Å°´Â °ÍÀÌ 1Â÷°¨¿° ¶Ç´Â Ãʰ¨¿°ÀÌ´Ù. ÀÌ 1Â÷°¨¿°ÀÇ º´ÅÍÀÇ º´¿øÃ¼°¡ Ç÷°ü-¸²ÇÁ°ü-±â°ü-¼ÒÈ­°ü-¿ä°ü µîÀÇ ±æÀ» µû¶ó °°Àº ±â°üÀÇ ´Ù¸¥ ºÎÀ§³ª ´Ù¸¥ ±â°üÀ¸·Î ¿î¹ÝµÇ¾î °¨¿°À» ÀÏÀ¸Å²´Ù. µû¶ó¼­ 1Â÷°¨¿°¿¡ ÀÇÇÏ¿© ÃæºÐÇÑ ¸é¿ªÀÌ µÉ °æ¿ì¿¡´Â 2Â÷°¨¿°ÀÌ ÀϾÁö ¾Ê´Â´Ù. ¿¹¸¦ µé¾î, À¯Ç༺ °¨±â¿¡ °É·ÈÀ» ¶§ ¼¼±Õ¿¡ ÀÇÇÑ Æó·ÅÀÌ µÚµû¸£´Â °æ¿ì¸¦ À̸¥´Ù. Æó·Å±Õ, È­³ó¾Ë±Õ, ´ëÀå±Õ µûÀ§°¡ ÀÖ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cowdry type A inclusion bodies
    Ä«¿ìµå¸®AÇüÆ÷ÇÔü, Ä«¿ìµå¸®AÇüºÀÀÔü
  • Cowdry type B inclusion bodies
    Ä«¿ìµå¸®BÇüÆ÷ÇÔü, Ä«¿ìµå¸®BÇüºÀÀÔü
  • crystalloid inclusion
    °áÁ¤Æ÷ÇÔ¹°
  • cytomegalic inclusion
    ¼¼Æ÷°Å´ëÆ÷ÇÔ¹°
  • cytomegalic inclusion body
    ¼¼Æ÷°Å´ëÆ÷ÇÔü, ¼¼Æ÷°Å´ëºÀÀÔü
  • cytomegalic inclusion disease
    °Å´ë¼¼Æ÷Æ÷ÇÔº´, °Å´ë¼¼Æ÷ºÀÀÔüº´
  • cytoplasmic inclusion body
    ¼¼Æ÷ÁúÆ÷ÇÔü, ¼¼Æ÷ÁúºÀÀÔü
  • cell inclusion
    ¼¼Æ÷Æ÷ÇÔ¹°, ¼¼Æ÷ºÀÀÔü
  • epidermal inclusion cyst
    Ç¥ÇǺÀÀÔ³¶, Ç¥ÇÇÆ÷ÇÔ³¶
  • germinal inclusion cyst
    ¹è»óÇǺÀÀÔ³¶, ¹è»óÇÇÆ÷ÇÔ¹°³¶
  • hyaline inclusion
    À¯¸®ÁúÆ÷ÇÔ¹°, À¯¸®ÁúºÀÀÔü
  • inclusion
    1. Æ÷ÇÔ¹°, ºÀÀÔü 2. ºÀÀÔ
  • inclusion blennorrhea
    ºÀÀÔü°í¸§´«¹°, ºÀÀÔü³ó·ç
  • inclusion body
    Æ÷ÇÔü, ºÀÀÔü
  • inclusion body fibromatosis
    Æ÷ÇÔü¼¶À¯Á¾Áõ, ºÀÀÔü¼¶À¯Á¾Áõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • germinal inclusion cyst
    ¹è»óÇǺÀÀÔ³¶, ¹è»óÇÇÆ÷ÇÔ¹°³¶
  • secondary sexual character
    ÀÌÂ÷¼ºÂ¡
  • secondary wound closure
    ÀÌÂ÷»óóºÀÇÕ
  • secondary dentition
    (¢¡permanent tooth) °£´Ï, ¿µ±¸Ä¡¾Æ
  • secondary hemostasis
    ÀÌÂ÷ÁöÇ÷
  • secondary infection
    ÀÌÂ÷°¨¿°
  • secondary nodule
    (¢¡germinal center) Á¾ÀÚÁß½É, ¹èÁß½É
  • secondary
    ÀÌÂ÷-, Á¦ÀÌ-, ¼Ó¹ß-
  • secondary suture
    ÀÌÂ÷ºÀÇÕ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytomegalic inclusion body
    ¼¼Æ÷°Å´ëºÀÀÔü, ¼¼Æ÷°Å´ëÆ÷ÇÔü
  • cytoplasmic inclusion body
    ¼¼Æ÷ÁúÆ÷ÇÔü
  • inclusion blennorrhea
    ºÀÀÔü°í¸§´«¹°
  • inclusion body
    Æ÷ÇÔü, ºÀÀÔü
  • intracellular inclusion body
    ¼¼Æ÷³»Æ÷ÇÔü
  • intranuclear inclusion body
    ÇÙÆ÷ÇÔü
  • cell inclusion
    ¼¼Æ÷Æ÷ÇÔ¹°
  • crystalloid inclusion
    °áÁ¤Æ÷ÇÔ¹°
  • cytomegalic inclusion
    ¼¼Æ÷°Å´ëÆ÷ÇÔ¹°
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÆ÷ÇÔº´
  • epidermal inclusion cyst
    Ç¥ÇÇÆ÷ÇÔ³¶
  • inclusion cast
    Æ÷ÇÔü¿øÁÖ
  • inclusion cyst
    Æ÷ÇÔ¹°³¶, ºÀÀÔ³¶
  • inclusion/exclusion criteria
    Æ÷ÇÔÁ¦¿Ü±âÁØ
  • inclusion disease
    Æ÷ÇÔº´, ºÀÀÔº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • haploid secondary gametocyte
    Ȭ¹è¼öüÀÌÂ÷»ý½Ä¼¼Æ÷
  • immune response, secondary
    ÀÌÂ÷¸é¿ª¹ÝÀÀ
  • immunodeficiency syndrome, secondary
    ÀÌÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¼Ó¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
  • infection, secondary
    ÀÌÂ÷°¨¿°
  • process, secondary (psychic)
    ÀÌÂ÷°úÁ¤.
  • acute inclusion body encephalitis
    ±Þ¼º ºÀÀÔü³ú¿°(¡­Üæìýô÷Òàæú).
  • inclusion blennorrhea
    ºÀÀÔü³ó·ç¾È.
  • inclusion body
    ºÀÀÔü
  • inclusion body disease
    ºÀÀÔüº´.
  • inclusion body fibromatosis
    ºÀÀÔü ¼¶À¯Á¾Áõ
  • inclusion body myositis
    ºÀÀÔü ±Ù¿°(¡­ÐÉæú)
  • inclusion body, cytoplasmic
    ¼¼Æ÷Áú³» ºÀÀÔü
  • inclusion body, intracytoplasmic
    ¼¼Æ÷³»ºÀÀÔü
  • inclusion cast
    ºÀÀÔü¿øÁÖ
  • inclusion conjunctivities
    ºÀÀÔü °á¸·¿°(¡­Ì¿Ø¯æú)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • secondary inclusion
    ÀÌÂ÷ºÀÀÔü(¡­Üæìýô÷).
  • secondary inclusion
    ÀÌÂ÷ºÀÀÔü(¡­Üæìýô÷)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytomegalic inclusion body = cytomegalic inclusion
    ¼¼Æ÷°Å´ë ºÀÀÔü(á¬øàËÝÓÞ Üæìýô÷)
  • secondary yolk sac [secondary vitelline sac]
    ÀÌÂ÷³­È²ÁÖ¸Ó´Ï
  • acute inclusion body encephalitis
    ±Þ¼º ºÀÀÔü³ú¿°(¡­Üæìýô÷Òàæú).
  • body, inclusion
    ºÀÀÔü
  • conjunctivits, inclusion
    ºÀÀÔü °á¸·¿°
  • crystalloid inclusion
    °áÁ¤Æ÷ÇÔ¹°
  • cytomegalic inclusion
    °Å´ë¼¼Æ÷ºÀÀÔü(ËÝÓÞá¬øàÜæìýô÷)
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë ºÀÀÔü º´
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÈ­ ºÀÀÔüº´
  • cytomegalic inclusion disease =CID
    ¼¼Æ÷°Å´ë¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =CID
    ¼¼Æ÷°Å´ë¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =CID
    °Å´ë¼¼Æ÷ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =cid
    °Å´ë¼¼Æ÷¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(¡­òðü´)
  • cytoplasmic inclusion body
    ¼¼Æ÷Áú³» ºÀÀÔü
  • eosinophilic inclusion body
    È£»ê¼º ºÀÀÔü.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Secondary yolk sac [Secondary vitelline sac]
    ÀÌÂ÷³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÌÂ÷³­È²³¶
  • Crystalloid inclusion
    °áÁ¤Æ÷ÇÔ¹°
    [¿¾ ¿ë¾î] °áÁ¤¾çÆ÷ÇÔ¹°
  • Fetal inclusion
    ºÀÀÔžÆ
    [¿¾ ¿ë¾î] ºÀÀÔ±âÇüžÆ
  • Mitochondrial inclusion
    »ç¸³Ã¼Æ÷ÇÔ¹°
    [¿¾ ¿ë¾î] »ç¸³Ã¼Æ÷ÇÔ¹°
  • Secondary segmental bronchus
    ±¸¿ª±â°üÁö°¡Áö
    [¿¾ ¿ë¾î] ÀÌÂ÷±¸±â°üÁö
  • Secondary tympanic membrane
    µÑ°°í¸·
    [¿¾ ¿ë¾î] Á¦ÀÌ°í¸·
  • Secondary spiral lamina
    µÑ°³ª¼±ÆÇ
    [¿¾ ¿ë¾î] Á¦2³ª¼±ÆÇ
  • Secondary fissure
    µÑ°ƴ»õ
    [¿¾ ¿ë¾î] Á¦2¿­
  • Secondary polar body
    ÀÌÂ÷±ØÃ¼
    [¿¾ ¿ë¾î] ÀÌÂ÷±ØÃ¼
  • Secondary oocyte
    ÀÌÂ÷³­¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷³­¸ð¼¼Æ÷
  • Secondary oocyte, Metaphase II
    ÀÌÂ÷³­¸ð¼¼Æ÷, ÀÌÂ÷°¨¼öºÐ¿­Áß±â
    [¿¾ ¿ë¾î] Á¦À̳­¸ð¼¼Æ÷,ÀÌÂ÷Áß±â
  • Secondary follicle
    ÀÌÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷³­Æ÷
  • Secondary ovarian follicle
    ÀÌÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷³­Æ÷
  • Secondary visceral nucleus
    ÀÌÂ÷³»Àå½Å°æÇÙ
    [¿¾ ¿ë¾î] Á¦2Àå½Å°æÇÙ
  • Secondary abdominal implantation
    ÀÌÂ÷¹è¾ÈÂø»ó
    [¿¾ ¿ë¾î] ÀÌÂ÷Àûº¹ºÎÂø»ó
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytoplasmic inclusion
    ¼¼Æ÷ÁúºÀÀÔü
  • secondary amebic meningoencephalitis
    ÀÌÂ÷¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • secondary echinococcosis
    ÀÌÂ÷Æ÷ÃæÁõ
  • secondary infection
    ÀÌÂ÷°¨¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • secondary acidosis
    ÀÌÂ÷ »êÁõ(ì£ó­ß«ñø)
  • secondary active transport
    ÀÌÂ÷ ´Éµ¿¼ö¼Û(ì£ó­ÒöÔÑâÃáê)
  • secondary alkalosis
    ÀÌÂ÷(ì£ó­) ¾ËÄ®¸®Áõ(ñø)
  • secondary bile acid
    ÀÌÂ÷ ´ãÁó»ê(ì£ó­ÓÅñðß«)
  • secondary bond
    ÀÌÂ÷ °áÇÕ(ì£ó­Ì¿ùê)
  • secondary charge effect
    ÀÌÂ÷ ÇÏÀüÈ¿°ú(ì£ó­ùÃï³üùÍý)
  • secondary culture
    ÀÌÂ÷ ¹è¾ç(ì£ó­ÛÆå×)
  • secondary deficiency
    ÀÌÂ÷ °áÇÌ(ì£ó­ÌÀù¹)
  • secondary derived protein
    ÀÌÂ÷ À¯µµ´Ü¹éÁú(ì£ó­ë¯ÓôÓ±ÛÜòõ)
  • secondary electron
    ÀÌÂ÷ ÀüÀÚ(ì£ó­ï³í­)
  • secondary fluor
    ÀÌÂ÷ Çü±¤Á¦(ì£ó­û«ÎÃð¥)
  • secondary hydration shell
    ÀÌÂ÷(ì£ó­) ¼öÈ­ â©ûù ²®Áú
  • secondary ionization
    ÀÌÂ÷(ì£ó­) ÀÌ¿ÂÈ­(ûù)
  • secondary ion mass spectrometry
    ÀÌÂ÷ ÀÌ¿ÂÁú·®ºÐ±¤¹ý(ì£ó­òõÕáÝÂÎÃÛö)
  • secondary isotope effect
    ÀÌÂ÷ µ¿À§¿ø¼ÒÈ¿°ú(ì£ó­ÔÒêÈêªáÈüùÍý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophilic inclusion body
    È£»ê¼ººÀÀÔü
  • inclusion body
    ºÀÀÔü
  • inclusion cyst
    ³¶ÀÔ³¶
  • secondary
    ÀÌÂ÷(¼º)ÀÇ, ¼Ó¹ß(¼º)ÀÇ
  • secondary anemia
    ¼Ó¹ß¼ººóÇ÷
  • secondary infection
    ÀÌÂ÷°¨¿°, ¼Ó¹ß°¨¿°
  • secondary lesion
    ÀÌÂ÷¼ºº´º¯, ÀÌÂ÷¹ßÁø, ¼Ó¹ßÁø
  • secondary ossification center
    ÀÌÂ÷°ñÈ­Áß½É
  • secondary pneumonia
    ¼Ó¹ß¼ºÆó·Å
  • secondary sex characteristic
    ÀÌÂ÷¼ºÂ¡
  • secondary sterility
    ¼Ó¹ßºÒÀÓ
  • secondary tuberculosis
    ÀÌÂ÷¼º°áÇÙ
  • secondary X-ray
    ÀÌÂ÷X¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SA salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame...
CID   1) Carpal Instability Dissociative; ÇØ¸®¼º ÁÖ±Ù°üÀý ºÒ¾ÈÁ¤¼º
  2) Cytomegalic Inclusio...
AIE acute inclusion-body encephalitis; acute infectious encephalitis; acute infective endocarditis
BII beat inclusion index; Billroth II [operation]; butanol-insoluble iodine
CIBHA congenital inclusion-body hemolytic anemia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GPIC Guinea pig inclusion conjunctivitis
IBH Inclusion Body Hepatitis
IB Inclusion bodies
IBM Inclusion body myositis
LBHI Lewy body-like hyaline inclusion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute inclusion body encephalitis
    ±Þ¼º ºÀÀÔü ³ú¿°
  • cytomegalic inclusion
    °Å´ë ¼¼Æ÷ ºÀÀÔü
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë¼º ºÀÀÔü º´, °Å´ë ¼¼Æ÷ ºÀÀÔü Áúȯ
  • eosinophilic inclusion body
    È£»ê±¸¼º ºÀÀÔü
  • epidermal inclusion cyst
    Ç¥ÇǼº ºÀÀÔ ³¶Á¾
    »óÇÇ ³¶Á¾ÀÇ ÀÏÁ¾À¸·Î ³¶º®ÀÌ Ç¥ÇÇ¿Í °ÅÀÇ Â÷À̰¡ ¾øÀ¸¸ç ÃþÆÇ »ó °¢Áú·Î Â÷ ÀÖ´Ù.
  • epithelial inclusion
    »óÇÇ ºÀÀÔ
  • inclusion bodies
    ºÀÀÔü, ºÀÀÔ ¼Òü
    ¼¼Æ÷ÀÇ ¼¼Æ÷Áú ³»Áö ÇÙÁú ³»¿¡ ³ªÅ¸³ª´Â ±¸Çü ¶Ç´Â ³­ÇüÀÇ ºÒ±ÔÄ¢ÇÑ ¼ÒüÀ̸ç, ±¤°ßº´, µÎâ, ÇãÇǽº¿Í °°Àº ¿©°ú¼º ¹ÙÀÌ·¯½º¿¡ ÀÇÇÑ °¨¿°Áõ¿¡¼­ º¼ ¼ö ÀÖ´Ù.
  • inclusion body disease
    ºÀÀÔü º´
    ¼¼Æ÷ ºÀÀÔü°¡ ³ªÅ¸³ª´Â Áúȯ. ƯÈ÷ ¹ÙÀÌ·¯½º º´¿¡¼­ ÈçÇÏ´Ù.
  • primary inclusion
    ÀÏÂ÷ ºÀÀÔü
  • viral inclusion
    ¹ÙÀÌ·¯½º ºÀÀÔ, ¹ÙÀÌ·¯½º ºÀÀÔü, ¹ÙÀÌ·¯½º¼º ºÀÀÔ, ¹ÙÀÌ·¯½º¼º ºÀÀÔü
  • brain vesicle`s secondary
    ÀÌÂ÷ ³úÆ÷
    Èı⠹èÅ ºÐÈ­·Î Çü¼ºµÇ´Â ³× °³ÀÇ ³ú³¶À¸·Î¼­ Àü³ú·ÎºÎÅÍ ºÐÈ­µÇ´Â Á¾³ú¿Í °£³ú, ´É³ú·ÎºÎÅÍ ºÐÈ­µÇ´Â Èijú¿Í ¼ö³ú¸¦ Æ÷ÇÔÇÑ´Ù.
  • secondary activation
    ÀÌÂ÷Àû Ȱ¼º
  • secondary amine
    ÀÌÂ÷ ¾Æ¹Î
  • secondary anemia
    ¼Ó¹ß¼º ºóÇ÷
  • secondary bond
    ÀÌÂ÷ °áÇÕ
    ÀϹÝÀûÀ¸·Î ¼ö¼Ò °áÇÕ, ¹Ýµ¥¸£¹ß½º Èû µîÀ» ¸»ÇÏ¸ç °áÇÕ·ÂÀº ÀÏÂ÷ °áÇշ¿¡ ºñÇÏ¸é ¸Å¿ì ÀÛ´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acute inclusion body encephalitis The most common acute encephalitis, caused by HSV-1; affects persons of any age; preferentially involves the inferomedial portions of the temporal lobe and the orbital portions of the frontal lobes; pathologically, severe haemorrhagic necrosis is present along with, in the acute stages, intranuclear eosinophilic inclusion bodies in the neurons and glial cells.
Synonym: acute inclusion body encephalitis, herpes encephalitis.
(05 Mar 2000)
conjunctivitis, inclusion An infection of the eyes characterised by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The aetiological agent is chlamydia trachomatis whose natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously.
(12 Dec 1998)
Cowdry's type A inclusion bodies Droplet-like masses of acidophilic material surrounded by clear halos within nuclei, with margination of chromatin on the nuclear membrane.
(05 Mar 2000)
Cowdry's type B inclusion bodies Droplet-like masses of acidophilic material surrounded by clear halos within nuclei, without other nuclear changes during early stages of development of the inclusion.
(05 Mar 2000)
myositis, inclusion body A progressive inflammatory myopathy primarily involving muscles of the pelvic region and legs, usually seen in older people. The muscles are infiltrated by mononuclear inflammatory cells, sarcoplasmic vacuoles, masses of filaments and filamentous microtubules, and sometimes eosinophilic bodies.
(12 Dec 1998)
cytomegalic inclusion disease <disease> An illness in newborns caused by viral infection, symptoms includefever, cellular enlargement, microscopically-visible clumps of viralparticles or proteins in the cytoplasm and nuclei of affected cells, enlargementof the spleen and liver. Long-term effects of the disease may includemental retardation.
(09 Oct 1997)
cytoplasmic inclusion bodies See: inclusion bodies.
(05 Mar 2000)
psittacosis inclusion bodies Intracytoplasmic chlamydial microcolonies observed in bronchial epithelial cells infected with Chlamydia psittaci.
(05 Mar 2000)
subacute inclusion body encephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
nuclear inclusion bodies See: inclusion bodies.
(05 Mar 2000)
inclusion 1. The act of including, or the state of being included; limitation; restriction; as, the lines of inclusion of his policy.
2. <chemical> A foreign substance, either liquid or solid, usually of minute size, inclosed in the mass of a mineral.
Origin: L. Inclusio: cf. F. Inclusion. See Include.
Source: Websters Dictionary
(01 Mar 1998)
inclusion blennorrhoea A neonatal conjunctivitis caused by Chlamydia trachomatis.
(05 Mar 2000)
inclusion bodies <cell biology> Nuclear or cytoplasmic structures with characteristic staining properties, usually found at the site of virus multiplication. Semi crystalline arrays of virions, capsids or other viral components.
(13 Nov 1997)
inclusion bodies, viral An area showing altered staining behaviour in the nucleus or cytoplasm of a virus-infected cell. Some inclusion bodies represent "virus factories" in which viral nucleic acid or protein is being synthesised; others are merely artifacts of fixation and staining. One example, negri bodies, are found in the cytoplasm or processes of nerve cells in animals that have died from rabies.
(12 Dec 1998)
inclusion body disease <disease> An illness in newborns caused by viral infection, symptoms includefever, cellular enlargement, microscopically-visible clumps of viralparticles or proteins in the cytoplasm and nuclei of affected cells, enlargementof the spleen and liver. Long-term effects of the disease may includemental retardation.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inclusion
    Æ÷ÇÔ
  • inclusion
    Æ÷ÇÔ;Æ÷°ý;»êÀÔ;(³í)Æ÷¼·;ÇÔÀ¯¹°;(»ý)¼¼Æ÷ÇÔÀ¯¹°;(ÁöÁú)Æ÷À¯¹°
  • inclusion body
    (ÀÇ)ºÀÀÔÁ¦
  • secondary
    Á¦ 2ÀÇ
  • post secondary education
    Áßµî °úÁ¤ ÈÄÀÇ ±³À°
  • secondary
    µÑ°ÀÇ;ÁßµîÀÇ;º¸Á¶ÀÚ;´ë¸®ÀÚ
  • secondary accent
    Á¦ 2¾×¼¾Æ®
  • secondary ballot
    °á¼± ÅõÇ¥
  • secondary base
    2·ç
  • secondary education
    Áßµî ±³À°
  • secondary industry
    Á¦ 2Â÷ »ê¾÷
  • secondary school
    Áßµî Çб³
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á